Annual Cash & Cash Equivalents
$142.15 M
-$231.89 M-62.00%
December 31, 2024
Summary
- As of March 10, 2025, NMRA annual cash & cash equivalents is $142.15 million, with the most recent change of -$231.89 million (-62.00%) on December 31, 2024.
- During the last 3 years, NMRA annual cash & cash equivalents has fallen by -$267.10 million (-65.27%).
- NMRA annual cash & cash equivalents is now -65.27% below its all-time high of $409.25 million, reached on December 31, 2021.
Performance
NMRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$142.15 M
-$133.57 M-48.44%
December 31, 2024
Summary
- As of March 10, 2025, NMRA quarterly cash and cash equivalents is $142.15 million, with the most recent change of -$133.57 million (-48.44%) on December 31, 2024.
- Over the past year, NMRA quarterly cash and cash equivalents has stayed the same.
- NMRA quarterly cash and cash equivalents is now -67.63% below its all-time high of $439.14 million, reached on September 1, 2021.
Performance
NMRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NMRA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.0% | 0.0% |
| 3 y3 years | -65.3% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
NMRA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.3% | at low | -65.5% | at low |
| 5 y | 5-year | -65.3% | -100.0% | -67.6% | at low |
| alltime | all time | -65.3% | -100.0% | -67.6% | at low |
Neumora Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $142.15 M(-62.0%) | $142.15 M(-48.4%) |
| Sep 2024 | - | $275.71 M(+83.0%) |
| Jun 2024 | - | $150.68 M(-17.6%) |
| Mar 2024 | - | $182.93 M(-51.1%) |
| Dec 2023 | $374.04 M(+55.2%) | $374.04 M(-9.3%) |
| Sep 2023 | - | $412.28 M(+101.9%) |
| Jun 2023 | - | $204.22 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $240.94 M(-41.1%) | $240.94 M(+38.2%) |
| Jun 2022 | - | $174.40 M(-40.1%) |
| Mar 2022 | - | $291.18 M(-28.9%) |
| Dec 2021 | $409.25 M(+113.2%) | - |
| Dec 2021 | - | $409.25 M(-6.8%) |
| Sep 2021 | - | $439.14 M(+128.7%) |
| Dec 2020 | $191.98 M(>+9900.0%) | $191.98 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Neumora Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Neumora Therapeutics?
- What is Neumora Therapeutics annual cash & cash equivalents year-on-year change?
- What is Neumora Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Neumora Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of NMRA is $142.15 M
What is the all time high annual cash & cash equivalents for Neumora Therapeutics?
Neumora Therapeutics all-time high annual cash & cash equivalents is $409.25 M
What is Neumora Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, NMRA annual cash & cash equivalents has changed by -$231.89 M (-62.00%)
What is Neumora Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NMRA is $142.15 M
What is the all time high quarterly cash and cash equivalents for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly cash and cash equivalents is $439.14 M
What is Neumora Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, NMRA quarterly cash and cash equivalents has changed by $0.00 (0.00%)